ZBH: Zimmer Biomet Corp Price to Sales

Symbol and logo of brand Zimmer Biomet Holdings Inc (ZBH)

Zimmer Biomet Holdings (ZBH) is strengthening its position through the greening of production and the reduction of its carbon footprint. The P/S ratio history confirms market resilience, where the value 2.20 reflects the metric's balance. Reliability is guaranteed by sterile express logistics of implants directly to clinics, while a stable cash flow is driven by the demographic trend of an aging population and the demand for elective surgery.

ZBH (Zimmer Biomet) P/S Multiple history from 07/04/2022 to 11/17/2026

Analytical breakdowns for Zimmer (ZBH)

- market capitalization information:
Fundamental company analysis:Zimmer Biomet Holdings Inc ZBH
Original product of Zimmer Biomet Corp

Investors must determine the extent of the premium paid for the business by comparing the market value of Zimmer Biomet Holdings (ZBH) with its operating income. When analyzing the current P/S valuation, it should be noted that a low multiple may signal an undervaluation of this implant market leader, whose position is strengthening through the implementation of ROSA robotic surgery and innovative smart patient monitoring systems.

Who Zimmer Biomet Holdings competes with

Market Cap to Revenue Boston Scientific Corporation BSX|P/S Multiple EW (Edwards Lifesciences)|ResMed Corp (RMD) - Price to Sales|Insulet Corp - P/S Multiple|COO (The Cooper Companies) - Market Cap to Revenue Ratio|ALGN: P/S Multiple|Market Cap to Revenue Ratio GMED|TMDX (TransMedics Corp) - P/S Multiple|ATEC Spine (ATEC) - Price-to-Revenue Coefficient|P/S Multiple AORT|Market Cap to Revenue Enovis Corporation ENOV|P/S Multiple IART (integralife.com)|P/S Multiple Establishment Labs Corp ESTA|BBNX - Price-to-Revenue Ratio|IRMD: Price-to-Revenue Ratio|EMBC (Embecta Corp.) - Market Cap to Revenue|Tandem Diabetes Care - Market Capitalization-to-Revenue Ratio|AXGN (Axogen Surgical) - P/S Multiple|Price to Sales SI-BONE Inc SIBN|Price-to-Revenue Ratio Orthofix Medical (OFIX)|P/S Multiple Bioventus Corp (BVS)|OrthoPediatrics Corp - Market Cap to Revenue|P/S Multiple Treace Medical Concepts TMCI|Blade Air Mobility - P/S Multiple|Price-to-Revenue Coefficient Carlsmed, Inc. CARL|RxSight (RXST) - Price-to-Revenue Ratio|Price-to-Sales Ratio CLPT (ClearPoint)|Price-to-Revenue Ratio stereotaxis.com|Market Cap to Revenue Neuronetics, Inc. (STIM)|P/S Multiple SGHT|OBIO - Price to Sales|Price-to-Revenue Ratio anikatherapeutics.com ANIK|NSPR: Market Cap to Revenue Ratio|ZJYL: Market Cap to Revenue|Vivani Medical Inc - Market Cap to Sales Volume|XTNT (Xtant Medical Holdings) - Market Cap to Revenue|Market Cap to Revenue Ratio NMTC|Price-to-Revenue Ratio Modular Medical Inc|Price to Sales Myomo Inc MYO|Market Cap to Revenue COCH (Envoy Medical, Inc.)|Price-to-Revenue Ratio VVOS (vivoslife.com)|enVVeno Medical Corp. - Market Cap to Revenue|Market Cap to Sales Volume SINT (sintx.com)|TNON - Price-to-Revenue Ratio|LFWD: Price-to-Revenue Ratio|autonomix.com (AMIX) - Price-to-Revenue Ratio|Price to Sales invobioscience.com (IVF)|BBLG (Bone Biologics Corp.) - P/S Multiple|Axonics Modulation Technologies (AXNX) - Price-to-Revenue Coefficient|Market Cap to Revenue BIOL (Biolase, Inc.)|Dynatronics - Market Cap to Revenue Ratio|Paragon 28, Inc. - Market Cap to Revenue|Price-to-Revenue Coefficient INVO Bio (INVO)